智通财经APP获悉，天风证券发布研究报告称，维持信达生物(01801)“买入”评级，考虑到公司已上市产品持续放量，多条研发管线即将进入产品收获期，将2024和2025年的收入预期分别从72.25、91.93亿元上调至79.70、102.35亿元，预计 ...

【解剖大盘】A股终于开盘，经过国庆的发酵，开盘即出现井喷。沪指高开10.13%，达到3674.4点，创业板指高开幅度高达18.44%。成交量首次突破三万亿，达到3.45万亿的历史巨量，上涨股票超5000只，市场呈现一片牛市欣欣向荣景象。而港股这边画风 ...

a recombinant anti-IGF-1R monoclonal antibody. Additionally, it distributes pharmaceutical products; and provides consultation, and research and development services. Innovent Biologics ...

GLP-1 receptor agonists are a non-insulin type 2 diabetes medication. GLP-1 agonists help to lower blood sugar and aid in weight loss. Drugs in this class include Byetta (exenatide), Victoza ...

Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common chronic liver disease globally and is currently estimated to affect up to 38% of the global adult population. NAFLD is a ...

Get your thinking caps on for another brainteaser from Mollie!